Pattern of intravenous proton pump inhibitors use in ICU and Non-ICU setting: A prospective observational study
Authors:
Open Access
- 1 January 2010
- journal article
- research article
- Published by Medknow in Saudi Journal of Gastroenterology
- Vol. 16 (4) , 275-9
Abstract
Background/Aim: The use of intravenous acid-suppressive therapy for stress ulcer prophylaxis in critically ill patients with specific risk factors has been recommended for over a decade. However, there is a lack of supporting data regarding the extension of such therapy to non-critically ill patients (non-ICU). The aim of this study was to compare appropriate indications with current practicing patterns in adult non-ICU and ICU patients, contributing factors and financial impact of inappropriate use. Materials and Methods: A prospective cross-sectional study was carried out at a tertiary teaching Hospital in Riyadh, Saudi Arabia. For a period of 4 consecutive months, all hospitalized patients on IV PPI, aged 18 and above, were identified. A concise listing of indications considered appropriate for the use of IV PPI was pre-defined based on material from available literature and guidelines. Results: A total of 255 patients received IV PPI. Inappropriate use of IV PPI was significantly higher in non-ICU (71.7%) than in ICU (19.8%) patients (P=0.01). The most common cause for inappropriate use in non-ICU patients was stress ulcer prophylaxis (SUP). In ICU patients, appropriate indicators for IV PPI were SUP (47.9%), PUD (11.5%), and the UGIB (20.8%). There was a high association between appropriate uses of IV PPI with respect to endoscopic procedure and also between appropriate uses of IV PPI to subsequent discharge with oral PPI in non-ICU patients. The total estimated direct cost (drug acquisition cost) for inappropriate use of IV PPI during the study period was 11,000 US dollars. Conclusion: Inappropriate IV PPI utilization was predominant in non-ICU patients, mostly for stress ulcer prophylaxis that leads to a waste of resources. Applying appropriate policies, procedures and evidence-based guidelines, educated physicians and surgeons can clearly limit inappropriate IV PPI use.Keywords
This publication has 21 references indexed in Scilit:
- Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.Alimentary Pharmacology & Therapeutics, 2008
- Stress ulcer prophylaxis in hospitalized patients not in intensive care unitsAmerican Journal of Health-System Pharmacy, 2007
- Magnitude and Economic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non-ICU Hospitalized PatientsAmerican Journal of Gastroenterology, 2006
- Hospital‐acquired gastrointestinal bleeding outside the critical care unit: Risk factors, role of acid suppression, and endoscopy findingsJournal of Hospital Medicine, 2006
- Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A meta-analysisWorld Journal of Gastroenterology, 2005
- Hospital use of acid‐suppressive medications and its fall‐out on prescribing in general practice: a 1‐month surveyAlimentary Pharmacology & Therapeutics, 2003
- Pathophysiology of the upper gastrointestinal tract in the critically ill patient: Rationale for the therapeutic benefits of acid suppressionCritical Care Medicine, 2002
- Overuse of acid-suppressive therapy in hospitalized patients1American Journal of Gastroenterology, 2000
- ASHP Therapeutic Guidelines on Stress Ulcer ProphylaxisAmerican Journal of Health-System Pharmacy, 1999
- Risk Factors for Gastrointestinal Bleeding in Critically Ill PatientsNew England Journal of Medicine, 1994